Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Personal Care Will Be California Green Chemistry “Test Case” – Council

This article was originally published in The Rose Sheet

Executive Summary

California’s Department of Toxic Substances Control is likely to target personal care with the next iteration of the Regulation for Safer Consumer Products enactment of which has been delayed due to widespread stakeholder concerns.

You may also be interested in...



California DTSC No Longer Singles Out Personal Care, But Increased Scrutiny Likely

Previous versions of California’s Regulation for Safer Consumer Products called out personal-care products as one of the first product groups targeted for evaluation. The latest version doesn’t name names, but the Personal Care Products Council is still wary.

“Multi-Attribute” Cradle-To-Cradle Seal: The Ultimate In Sustainability?

For brands looking to cover all their bases in corporate responsibility with one certification – from ingredient safety to sourcing and environmental impact – Cradle to Cradle certification may be the right investment.

“Multi-Attribute” Cradle-To-Cradle Seal: The Ultimate In Sustainability?

For brands looking to cover all their bases in corporate responsibility with one certification – from ingredient safety to sourcing and environmental impact – Cradle to Cradle certification may be the right investment.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017611

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel